HIMALAYA NUTRAVEDICS INDIA LIMITED
BSE: HNIL544943ISIN INE1OTR01013
- Healthcare
- Pharmaceuticals
- BSE SME IPO
Share price
₹134.35-15.25 (-10.19%)
as of 19 Oct 2026
Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.
- 52W high
- ₹167.20
- 52W low
- ₹111.00
- Off 52W high
- -19.65%
- 1M return
- —
- 3M return
- —
- 6M return
- —
- 1Y return
- —
- 20D avg volume
- —
- 50 DMA
- —
- 200 DMA
- —
Key ratios Consolidated
- Market cap
- ₹118.31 Cr
- Current price
- ₹134.35
- 52W high / low
- ₹167.20 / ₹111.00
- Face value
- ₹10.00
- P/E
- —
- P/B
- —
- EPS (TTM)
- —
- Book value / share
- —
- ROE
- —
- ROCE
- —
- Operating margin
- —
- Net margin
- —
- Debt / equity
- —
- Net debt
- —
- Interest cover
- —
- Dividend yield
- —
- Dividend / share (TTM)
- —
- Payout
- —
- Cash conversion cycle
- —
Financials
| Metric | FY26 | FY25 | FY24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43.07 | 21.00 | 14.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7.39 | 2.23 | 0.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key metrics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17.20% | 10.60% | 3.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105.10% | 45.50% | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 231.40% | 418.60% | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compounded growth
- Sales CAGR 3Y
- —
- Sales CAGR 5Y
- —
- Profit CAGR 3Y
- —
- Profit CAGR 5Y
- —
- Sales YoY (TTM)
- —
- Profit YoY (TTM)
- —
Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.
Peer comparison
| Company | Mkt cap (₹ Cr) | Price (₹) | P/E | ROCE | Sales YoY | Profit YoY | 1Y return |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,18,674 | 1,760.00 | 34.85 | 17.90% | +11.41% TTM | +16.54% TTM | +6.04% |
| Divi's Laboratories Ltd. | 2,41,311 | 9,220.00 | 83.68 | 19.00% | +16.35% TTM | +26.84% TTM | +39.74% |
| Torrent Pharmaceuticals Ltd. | 1,73,073 | 4,560.00 | 80.45 | 9.10% | +32.85% TTM | +7.69% TTM | +29.05% |
| Laurus Labs Limited | 1,11,434 | 2,059.00 | 102.00 | 19.70% | +22.62% TTM | +114.95% TTM | +135.84% |
| Zydus Lifesciences Limited | 1,11,022 | 1,124.30 | 24.42 | 19.20% | +21.11% TTM | -2.51% TTM | +14.26% |
| Cipla Ltd. | 1,07,528 | 1,325.00 | 31.90 | 14.90% | +1.85% TTM | -37.69% TTM | -15.53% |
| Dr. Reddy's Laboratories Ltd. | 1,03,662 | 1,231.85 | 32.30 | 13.90% | -0.87% TTM | -44.57% TTM | -0.66% |
| Mankind Pharma Limited | 93,014 | 2,275.00 | 45.45 | 13.70% | +13.75% TTM | +8.10% TTM | -7.32% |
| Aurobindo Pharma Ltd. | 92,924 | 1,660.00 | 25.74 | 13.60% | +9.09% TTM | +9.48% TTM | +50.12% |
| Lupin Ltd | 89,343 | 1,955.80 | 16.11 | 28.40% | +28.19% TTM | +49.13% TTM | +0.27% |
| Glenmark Pharmaceuticals ltd | 62,339 | 2,224.00 | 34.91 | 16.20% | +32.94% TTM | +138.48% TTM | +19.23% |
| Alkem Laboratories Limited | 59,723 | 5,135.60 | 27.86 | 18.80% | +13.36% TTM | -5.52% TTM | -7.85% |
| Biocon Ltd. | 55,491 | 350.00 | 136.98 | 2.90% | +9.83% TTM | -36.60% TTM | -2.26% |
| Abbott India Ltd. S | 54,910 | 26,154.85 | 34.42 | 41.90% | +6.29% TTM | +11.18% TTM | -12.34% |
| Gland Pharma Limited | 49,953 | 3,043.20 | 44.49 | 13.70% | +17.57% TTM | +46.55% TTM | +58.50% |
| Ipca Laboratories Ltd. | 46,042 | 1,836.50 | 33.88 | 16.40% | +10.59% TTM | +67.91% TTM | +42.60% |
| GlaxoSmithkline Pharmaceuticals Ltd. | 42,177 | 2,565.20 | 40.68 | 55.40% | +5.75% TTM | +12.41% TTM | -5.98% |
| Ajanta Pharma Ltd. | 41,241 | 3,323.05 | 36.59 | 29.40% | +20.19% TTM | +22.04% TTM | +34.31% |
| J.B. Chemicals & Pharmaceuticals Lt | 38,731 | 2,412.25 | 47.77 | 21.90% | +5.87% TTM | +7.56% TTM | +45.79% |
| Emcure Pharmaceuticals Limited | 33,487 | 1,823.10 | 33.94 | 25.10% | +18.36% TTM | +32.39% TTM | +35.25% |
| Wockhardt Ltd | 30,977 | 1,949.25 | 76.51 | 6.40% | +18.37% TTM | +377.85% TTM | +43.61% |
| Sai Life Sciences Limited | 29,679 | 1,395.65 | 81.95 | 18.10% | — | — | +62.81% |
| ACUTAAS CHEMICALS LIMITED | 26,649 | 3,203.05 | 67.70 | 27.70% | +40.91% TTM | +104.14% TTM | +106.35% |
| PIRAMAL PHARMA LIMITED | 25,888 | 194.30 | -82.48 | 0.80% | +0.78% TTM | -419.79% TTM | +0.39% |
| Neuland Laboratories Limited. | 24,665 | 19,699.70 | 50.78 | 23.10% | +78.33% TTM | +182.59% TTM | +21.73% |
| HIMALAYA NUTRAVEDICS INDIA LIMITED | 118 | 134.35 | — | — | +105.10% FY26 | +231.39% FY26 | — |
Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.
Filings & corporate actions
Recent announcements
- Reply to the clarification sought with regard to the Price movement
- for the quarter ended 30th September 2026
- The Exchange has sought clarification from Himalaya Nutravedics India Ltd on October 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....
- Kindly find the enclosed disclosure
- Investor presentation FY 2026
- Closure of trading window
- Trading Members of the Exchange are hereby informed that effective from September 29, 2026, the Equity Shares of Himalaya Nutravedics India Ltd (Scrip Code: 544943) are listed and admitted ....